Sean F. Scanlan, SVP, Marketing at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 2,300 shares at $20.02 ($46K) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Scheduled sale ($46k) by SVP, Marketing under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 1,000 | $20K | 43.5% |
| 2 | $20.00 | 500 | $10K | 21.7% |
| 3 | $20.02 | 800 | $16K | 34.8% |
| Total | $20.02 avg | 2,300 | $46K | 100% |
| Filing → |
| TMCI | SELL | 2023-03-10 | $12K | — | Filing → |
| TMCI | SELL | 2023-02-17 | $542K | — | Filing → |
| TMCI | SELL | 2023-01-13 | $639K | — | Filing → |